my mhealth secures £2.2m in grant funding from Eurostars for its heart health project.
The grant will support the development of the CUOREMA project with international collaborators.
NHS-approved digital therapeutics pioneer providing remote management applications for long-term health conditions. The firm develops evidence-based software to support patients dealing with respiratory and cardiac diseases.
Digital therapeutics provider my mhealth has secured a grant worth £2.2m from Eurostars to advance its cardiac rehabilitation technology. The funding will support the development of the CUOREMA project, an immersive app incorporating biofeedback and gamification to improve patient outcomes.
The initiative brings together European collaborators including Ospedale Malcantonese, Games for Health, and the University of Applied Sciences and Arts of Southern Switzerland. Innovate UK is sponsoring the British firm as part of the wider European programme.
From the founder
"We are thrilled to be partnering with such talented and diverse teams on this innovative and important project over the next few years. Each organisation brings a very unique perspective to the table, allowing for a thoughtful and comprehensive approach to tackling heart health. I am extremely passionate about digital health and this has the potential to change many lives for the better, helping us transform cardiac rehabilitation for patients across Europe."
Simon Bourne
Chief Executive Officer at my mhealth
Use of funds
- 01Fund research and development
- 02Continue product development
Investors
Categories
About the company
my mhealth
Digital therapeutics company developing remote health management apps for long-term conditions.